Cas no 1420898-28-7 (Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate)
Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- Tert-butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate
- AM99351
- Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate
-
- Inchi: 1S/C13H26N2O2/c1-13(2,3)17-12(16)15-9-5-6-11(10-15)7-8-14-4/h11,14H,5-10H2,1-4H3
- InChI Key: UCAQXFPIQMJRAJ-UHFFFAOYSA-N
- SMILES: O(C(C)(C)C)C(N1CCCC(CCNC)C1)=O
Computed Properties
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 17
- Rotatable Bond Count: 5
- Complexity: 248
- Topological Polar Surface Area: 41.6
Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-1880344-1.0g |
tert-butyl 3-[2-(methylamino)ethyl]piperidine-1-carboxylate |
1420898-28-7 | 1g |
$0.0 | 2023-06-01 |
Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate Related Literature
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
Additional information on Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate
Comprehensive Guide to Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate (CAS No. 1420898-28-7)
Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate (CAS No. 1420898-28-7) is a specialized organic compound widely used in pharmaceutical research and fine chemical synthesis. This compound belongs to the class of piperidine derivatives, which are known for their versatile applications in drug discovery and development. With the increasing demand for novel bioactive molecules, Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate has gained significant attention due to its unique structural features and potential therapeutic applications.
The molecular structure of Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate includes a piperidine ring substituted with a methylaminoethyl group and a tert-butoxycarbonyl (Boc) protecting group. This combination makes it a valuable intermediate in the synthesis of more complex molecules, particularly in the field of central nervous system (CNS) drug development. Researchers often utilize this compound to explore new pathways for treating neurological disorders, a topic that has become increasingly relevant in recent years due to the rising prevalence of conditions such as Alzheimer's disease and Parkinson's disease.
One of the key advantages of Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate is its stability under various reaction conditions, making it suitable for multi-step synthetic processes. The Boc protecting group can be easily removed under mild acidic conditions, allowing for further functionalization of the piperidine core. This characteristic has made it a popular choice among medicinal chemists working on GPCR-targeted drugs, a hot topic in current pharmaceutical research given the importance of G protein-coupled receptors in numerous physiological processes.
In the context of current research trends, Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate is particularly interesting for scientists exploring novel antidepressant and anxiolytic compounds. The structural similarity of this molecule to known psychoactive substances has prompted investigations into its potential effects on neurotransmitter systems. However, it's important to note that all such research is conducted under strict ethical guidelines and regulatory oversight, focusing solely on legitimate scientific purposes.
The synthesis of Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate typically involves multi-step organic reactions starting from commercially available piperidine derivatives. Modern synthetic approaches often employ green chemistry principles, reflecting the growing emphasis on sustainable practices in chemical research. This aligns with current industry trends where environmental considerations are becoming as important as the scientific outcomes themselves.
From a commercial perspective, the demand for Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate has been steadily increasing, particularly from pharmaceutical companies and contract research organizations. The compound is typically supplied with high purity (>98%) and is available in various quantities to meet different research needs. Quality control measures for this chemical include rigorous HPLC analysis and spectroscopic characterization to ensure batch-to-batch consistency.
Storage and handling of Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate require standard laboratory precautions. The compound should be kept in a cool, dry place, protected from moisture and light. While it doesn't fall under any special regulatory category, proper laboratory safety protocols should always be followed when working with any chemical substance.
Recent scientific literature reveals growing interest in the potential applications of Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate derivatives. Several research groups have reported using this compound as a building block for neuroprotective agents and cognitive enhancers. These developments coincide with increased public awareness about brain health and mental well-being, making this area of research particularly timely.
The future outlook for Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate appears promising, with potential applications extending beyond its current uses. As drug discovery techniques become more sophisticated, particularly with the integration of AI-assisted molecular design, compounds with this structural motif may find new roles in addressing unmet medical needs. The pharmaceutical industry's continued focus on precision medicine and personalized therapeutics further underscores the importance of such specialized chemical building blocks.
For researchers considering working with Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate, it's worth noting that the compound offers excellent opportunities for structural modification. The presence of both amine and carbamate functionalities allows for diverse chemical transformations, enabling the creation of libraries of derivatives for biological evaluation. This approach aligns with current drug discovery paradigms that emphasize the screening of compound libraries to identify lead molecules.
In conclusion, Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate (CAS No. 1420898-28-7) represents an important tool in modern medicinal chemistry. Its unique structural features, combined with the growing understanding of piperidine-based therapeutics, position this compound as a valuable asset in the ongoing search for new and improved pharmaceutical agents. As research in neurological and psychiatric disorders continues to advance, the role of such specialized intermediates is likely to become even more significant in the years to come.
1420898-28-7 (Tert-Butyl 3-(2-(methylamino)ethyl)piperidine-1-carboxylate) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)